Timothy Savage, MD, MPH

Assistant in Pediatrics, Division of Infectious Diseases
Instructor of Medicine, Harvard Medical School
Image
Timothy Savage, MD, MPH

Timothy Savage, MD, MPH

Assistant in Pediatrics, Division of Infectious Diseases
Instructor of Medicine, Harvard Medical School

Medical Services

Languages
English
Education
Residency
Brown University
2008
Providence
RI
Graduate School
Icahn School of Medicine at Mount Sinai
2010
New York
NY
Medical School
Icahn School of Medicine at Mount Sinai
2014
New York
NY
Internship
Seattle Children's Hospital/University of Washington
2015
Seattle
WA
Residency
Seattle Children's Hospital/University of Washington
2017
Seatlle
WA
Residency
Chief Resident
Seattle Children's Hospital
2018
Seattle
WA
Fellowship
Boston Children's Hospital
2021
Boston
MA
Graduate School
Harvard T.H. Chan School of Public Health
2021
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Infectious Diseases)

Publications

Comparative effectiveness of metronidazole and vancomycin for treatment of Clostridioides difficile infection in hospitalized children. View Abstract
Error in Days for Outcome Ascertainment in Study Comparing Antibiotic Treatment of Acute Sinusitis in Children and Adolescents. View Abstract
Clarifying the Role of Antibiotics in Acute Sinusitis Treatment. View Abstract
Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis-Reply. View Abstract
Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis. View Abstract
Accuracy of identifying pediatric acute bacterial sinusitis diagnoses in outpatient claims data. View Abstract
Trends in the Antibiotic Treatment of Acute Sinusitis: 2003-2020. View Abstract
Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study. View Abstract
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion. View Abstract
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. View Abstract
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. View Abstract
Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019. View Abstract
Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship. View Abstract
Predictive Value of Direct Disk Diffusion Testing from Positive Blood Cultures in a Children's Hospital and Its Utility in Antimicrobial Stewardship. View Abstract
Toxocara Myopericarditis and Cardiac Magnetic Resonance Imaging in a Young Girl. View Abstract
Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay. View Abstract
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. View Abstract
Trends in clinical presentation of children with COVID-19: a systematic review of individual participant data. View Abstract
DENV inhibits type I IFN production in infected cells by cleaving human STING. View Abstract